Results 161 to 170 of about 16,303 (230)

Von Willebrand, factor VIII, and D-dimer levels as predictors of risk and clinical outcomes in acute myeloid leukemia. [PDF]

Clin Exp Med
El-Sayed HA, Sakr DH, Ebrahim MA, Alghandour R, Eid E, Denewer M, Saarsalu B, Othman M, Azzam H.   +8 more
europepmc   +1 more source

Acquired hemophilia A: an illustrated review based on the French National Guidelines. [PDF]

Res Pract Thromb Haemost
Guillet B, d'Oiron R, Lacroix-Desmazes S, Chamouard V, Aouba A, Castet S, Benhamou Y, Nougier C, Noel N, Repesse Y, Graveleau J, Trossaert M, Lévesque H, Dargaud Y.   +13 more
europepmc   +1 more source

Effectiveness and Safety of Prophylactic Low-Dose Emicizumab in Young Children With Hemophilia A: A Multicenter Retrospective Study. [PDF]

EJHaem
Zhou G, He L, Wang C, Deng Y, Peng D, Liu Z, Liu S, Fu X, Wang Y, Feng X.   +9 more
europepmc   +1 more source

Nonneutralizing Antibodies in Haemophilia A Patients: To Be Ignored or Not to Be! [PDF]

Haemophilia
Shetty S, Dhawlarker A, Kharat S, Patil K, Saini GK, Jivani F, Bharankar J, Kshirsagar S, Rangarajan S.   +8 more
europepmc   +1 more source

Burden of Treatment and Disease on People with Hemophilia: Global Real-World Survey. [PDF]

Patient Prefer Adherence
Castaman G, Percier C, Shridhar N, Reynolds N, Rajkovic-Hooley O, Dewar T, Jiménez-Yuste V.   +6 more
europepmc   +1 more source

Risk Stratification and Nursing Strategy for Recurrent Readmission in Primary Venous Thromboembolism: A Study Based on NT-proBNP and Factor VIII. [PDF]

Nurs Health Sci
Wang X, Li J, Yu Y, Zhang S, Bai Y, Guo X, Li Z.   +6 more
europepmc   +1 more source

Myeloid Cell Function and Cytokine Profiles in Paediatric Haemophilia A: Insights From FVIII and Emicizumab Prophylaxis. [PDF]

J Cell Mol Med
Cottonaro A, Akula S, Pollio B, Ricca I, Martini T, Albiani R, Giacchello JA, Sciancalepore P, Santi R, Follenzi A, Merlin S.   +10 more
europepmc   +1 more source

Individual Comparative PK Evaluation of Single-dose Octocog Alfa, Rurioctocog Alfa Pegol, and Efanesoctocog Alfa in Adults with Severe Hemophilia A. [PDF]

TH Open
Staber JM, Lissitchkov T, Chan AKC, Wilson AS, Dumont J, Willemze AJ.   +5 more
europepmc   +1 more source

Treatment satisfaction and patient preference for efanesoctocog alfa over previous hemophilia A treatment: Results from the XTEND-1 phase 3 clinical trial. [PDF]

Curr Ther Res Clin Exp
Spasov E, Quon D, Fukutake K, Willemze A, Dumont J, Palmborg H, Kragh N, Gerard E, Wilson A, Msihid J.   +9 more
europepmc   +1 more source

Preoperative identification and multidisciplinary management of von Willebrand disease in atrial septal defect closure: a case report. [PDF]

Front Cardiovasc Med
Peng W, Wei Q, Yang J, Liu X.
europepmc   +1 more source